Intravitreal injection of aflibercept, an anti-VEGF antagonist, down-regulates plasma von Willebrand factor in patients with age-related macular degeneration
Abstract We investigated the association between von Willebrand factor (VWF) and exudative age-related macular degeneration (AMD) in 114 Japanese patients. Intravitreal injection of vascular endothelial growth factor (VEGF) inhibitor is the most effective therapy for AMD. Therefore, we analyzed chan...
Saved in:
Main Authors: | Mariko Yamashita, Masanori Matsumoto, Masaki Hayakawa, Kazuya Sakai, Yoshihiro Fujimura, Nahoko Ogata |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/995d2842aecf46f6b17a2d1916c57f4d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analysis focusing on plasma von Willebrand factor in pachychoroid neovasculopathy and age-related macular degeneration
by: Hiromasa Hirai, et al.
Published: (2021) -
Response of serous retinal pigment epithelial detachments to intravitreal aflibercept in polypoidal choroidal vasculopathy refractory to ranibizumab
by: Yamashita M, et al.
Published: (2014) -
Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathy.
by: Kei Takayama, et al.
Published: (2021) -
Von Willebrand Disease in the elderly: clinical perspectives
by: Chapin J
Published: (2018) -
Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer—Single-Center Experience
by: Ingrid Skornova, et al.
Published: (2021)